PCBP2-OT1: A Non-Coding RNA Molecule with Potential as a Drug Target and Biomarker

Target Name: PCBP2-OT1

NCBI ID: G102157401

PCBP2-OT1

Other Name(s): PCBP2 overlapping transcript 1 | uc.338 | TUC.338 | PCBP2 overlapping transcript 1 (non-protein coding) | TUC338

PCBP2-OT1: A Non-Coding RNA Molecule with Potential as a Drug Target and Biomarker

PCBP2-OT1 (PCBP2 overlapping transcript 1) is a gene that encodes a protein known as PCBP2. PCBP2 is a non-coding RNA molecule that has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and invasion. The PCBP2 gene has been identified as a potential drug target and has the potential to be a biomarker for various diseases.

The PCBP2 gene was first identified in the genomic database using RNA-seq technology. The RNA-seq data revealed that PCBP2 was highly expressed in various tissues and organs, including brain, heart, liver, and muscle. The expression level of PCBP2 was also shown to be regulated by various factors, including growth factors, chemokines, and UV radiation.

Function and Interaction

PCBP2 is a non-coding RNA molecule that is involved in the regulation of gene expression. It is a key regulator of cell adhesion and has been shown to play a role in the regulation of cell migration and invasion. PCBP2 has been shown to interact with various protein molecules, including the transcription factor, NF-kappa-B, and the protein, p53.

PCBP2 has also been shown to play a role in the regulation of cellular processes that are important for human health, such as cancer progression and the development of neurodegenerative diseases. For example, studies have shown that PCBP2 is involved in the regulation of cell proliferation and has been shown to promote the growth of cancer cells.

Drug Target

PCBP2 is a potential drug target due to its involvement in various cellular processes that are important for human health. The PCBP2 gene has been shown to be involved in the regulation of cell adhesion, which is important for the development of various diseases, including cancer.

PCBP2 has also been shown to play a role in the regulation of cell migration and invasion, which are important for the development of various diseases, including neurodegenerative diseases.

Biomarker

PCBP2 has the potential to be a biomarker for various diseases due to its involvement in the regulation of various cellular processes that are important for human health. Studies have shown that PCBP2 is involved in the regulation of cell adhesion, which is important for the development of cancer.

In addition, PCBP2 has also been shown to play a role in the regulation of cell migration and invasion, which are important for the development of neurodegenerative diseases.

Conclusion

PCBP2-OT1 (PCBP2 overlapping transcript 1) is a gene that encodes a protein known as PCBP2. PCBP2 is a non-coding RNA molecule that has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and invasion. The PCBP2 gene has been identified as a potential drug target and has the potential to be a biomarker for various diseases. Further research is needed to fully understand the role of PCBP2 in the regulation of cellular processes and to develop effective treatments for various diseases.

Protein Name: PCBP2 Overlapping Transcript 1

The "PCBP2-OT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCBP2-OT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets